Signaling Mechanisms Underlying A&bgr; Toxicity: Potential Therapeutic Targets for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 355-361

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective effects of PPAR agonists against oxidative insults in HT-22 cells

By Aoun P.   Watson D.G.   Simpkins J.W.  

European Journal of Pharmacology, Vol. 472, Iss. 1, 2003-07 ,pp. : 65-71

Elsevier

Access to resources Recommend Favorite

Reduction of A&bgr; Levels in the Sprague Dawley Rat After Oral Administration of the Functional g-Secretase Inhibitor, DAPT: A Novel Non- Transgenic Model for A&bgr; Production Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 671-676

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Modulation of A&bgr;42 Production in Alzheimer's Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4337-4355

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of crocetin on the matrix metalloproteinases in cardiac hypertrophy induced by norepinephrine in rats

By Shen X.-C.   Y.-LU   Qian Z.-Y.  

Journal of Asian Natural Products Research, Vol. 8, Iss. 3, 2006-04 ,pp. : 201-208

Taylor & Francis Ltd

Access to resources Recommend Favorite